Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion type Assertion NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_head.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion description "[Overall, c-met protein staining was noted in 36 of 43 (84%) primary prostate cancer samples versus 2 of 11 (18%) benign prostate hyperplasia samples (p < 0.0001) and in 4 of 4 (100%) lymph node metastases, 23 of 23 (100%) bone marrow metastases and 1 of 3 (33%) other metastatic sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_provenance.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion evidence source_evidence_literature NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_provenance.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion SIO_000772 7539865 NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_provenance.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion wasDerivedFrom befree-20150227 NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_provenance.
- NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_assertion wasGeneratedBy ECO_0000203 NP554368.RArSM_5pcHSB4lccsW3KneR4oSP5cAg-kFmhaUp79ERc0130_provenance.